Aclaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research.

Medical - Diagnostics & Research
US, Wayne [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of ACRS's Analysis
CIK: 1557746 CUSIP: 00461U105 ISIN: US00461U1051 LEI: - UEI: -
Secondary Listings
ACRS has no secondary listings inside our databases.